The Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial

Atte Meretoja, Leonid Churilov, Bruce C. V. Campbell, Richard I. Aviv, Nawaf Yassi, Christen Barras, Peter Mitchell, Bernard Yan, Harshal Nandurkar, Christopher Bladin, Tissa Wijeratne, Neil J. Spratt, Jim Jannes, Jonathan Sturm, Jayantha Rupasinghe, Jorge Zavala, Andrew Lee, Timothy Kleinig, Romesh Markus, Candice DelcourtNeil Mahant, Mark W. Parsons, Christopher Levi, Craig S. Anderson, Geoffrey A. Donnan, Stephen M. Davis*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

65 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial'. Together they form a unique fingerprint.

Medicine and Dentistry